HomeAI · summaries
Storia in 8 fonti
AstraZeneca se derrumba en bolsa tras fracaso de ensayo clínico para fármaco cardíaco - La Tercera
Wainua no cumplió su objetivo principal en un estudio de fase avanzada para una rara condición cardíaca.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
AstraZeneca stock dives 9% after heart drug trial misses target
A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.
- ·
endpoints.news
AstraZeneca sinks on unexpected heart drug trial failure
AstraZeneca shares sink up to 9% after Wainua misses cardiovascular endpoint in Phase 3 ATTR-CM trial with partner Ionis.
